Medicare's Part B monthly premium is outpacing both inflation and Social Security's cost-of-living adjustment.

Medicare Part B premiums are rising again in 2025. The jump outpaces both Social Security's 2025 COLA and inflation, further ...

Medicare beneficiaries can expect to pay a little more than $10 a month next year for Part B coverage — but that’s not all ...

Medicare Advantage patients in the last year of life were far more likely to switch to traditional Medicare, shifting costs ...

On November 8, the Centers for Medicare and Medicaid Services announced the Medicare premiums and costs for 2025. Let’s take ...

As the former president reenters the White House, significant changes to Medicare could be on the horizon. Here's what to ...

Big Medicare Advantage insurance companies have filed lawsuits against the federal government, furiously attacking the ...

回顾历史，Medicare是在1965年由时任总统林登·约翰逊签署成为法律的，它最初是为65岁及以上的老年人提供医疗保险。这一举措标志着美国政府在社会保障领域迈出了重要一步。随着时间的推移，Medicare逐渐扩展，涵盖了更多的人群和服务项目，如残疾人士和某些长期病患者。如今，Medicare已成为美国最大的公共医疗保险计划之一，分为Part A（住院保险）、Part B（医疗保险）、Part C ...

When saving for healthcare costs in retirement, it's easy to forget about inflation, which continually drives up not only ...

However, after working towards a resolution that ensures better care for patients covered by UHC, Essentia Health agreed to ...

Experts say this is one of the most disruptive enrollment seasons for Medicare. Many will see fewer options, higher costs, ...

西雅图 - Adaptive Biotechnologies Corporation (NASDAQ:ADPT)今日宣布,其clonoSEQ检测获得Medicare承包商Palmetto GBA的扩大覆盖范围,将包括患有套细胞淋巴瘤(MCL)的Medicare患者。这一决定允许对这类患者进行可测量残留病变(MRD)的检测和监测。 MCL是非霍奇金淋巴瘤的一种亚型,在美国每年约有4,000例新病例。